Frazier Management as of Sept. 30, 2021
Portfolio Holdings for Frazier Management
Frazier Management holds 41 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | 16.1 | $202M | 8.4M | 23.89 | |
| Phathom Pharmaceuticals (PHAT) | 15.0 | $187M | 5.8M | 32.10 | |
| Mirum Pharmaceuticals (MIRM) | 5.7 | $71M | 3.6M | 19.92 | |
| Iovance Biotherapeutics (IOVA) | 5.3 | $66M | 2.7M | 24.66 | |
| Imago Biosciences | 4.8 | $60M | 3.0M | 20.03 | |
| Vaxcyte (PCVX) | 4.7 | $59M | 2.3M | 25.37 | |
| Trillium Therapeutics Com New | 4.4 | $55M | 3.1M | 17.61 | |
| Gritstone Oncology Ord (GRTS) | 4.0 | $50M | 4.7M | 10.80 | |
| Passage Bio (PASG) | 4.0 | $50M | 5.0M | 9.96 | |
| Krystal Biotech (KRYS) | 3.2 | $40M | 771k | 52.21 | |
| Tarsus Pharmaceuticals (TARS) | 2.4 | $31M | 1.4M | 21.55 | |
| Iveric Bio | 2.4 | $30M | 1.8M | 16.24 | |
| Sutro Biopharma (STRO) | 2.2 | $28M | 1.5M | 18.89 | |
| Miragen Therapeutics (VRDN) | 2.0 | $25M | 1.5M | 16.45 | |
| Anaptysbio Inc Common (ANAB) | 2.0 | $24M | 900k | 27.12 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.9 | $23M | 3.5M | 6.55 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $23M | 1.2M | 19.11 | |
| Tyra Biosciences (TYRA) | 1.8 | $22M | 1.3M | 17.59 | |
| Chinook Therapeutics | 1.7 | $21M | 1.7M | 12.76 | |
| Alpine Immune Sciences (ALPN) | 1.5 | $19M | 1.8M | 10.67 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.5 | $18M | 443k | 41.59 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.4 | $18M | 851k | 21.05 | |
| Sierra Oncology Com New | 1.4 | $18M | 805k | 21.92 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 1.2 | $15M | 1.5M | 10.03 | |
| Replimune Group (REPL) | 1.2 | $15M | 492k | 29.64 | |
| Gracell Biotechnologies Sponsored Ads | 0.9 | $12M | 852k | 13.87 | |
| Regenxbio Inc equity us cm (RGNX) | 0.8 | $9.9M | 236k | 41.92 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.7 | $9.3M | 952k | 9.80 | |
| Molecular Templates | 0.7 | $9.2M | 1.4M | 6.71 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $7.4M | 408k | 18.00 | |
| Scholar Rock Hldg Corp (SRRK) | 0.4 | $5.2M | 156k | 33.02 | |
| Immunovant (IMVT) | 0.4 | $5.1M | 586k | 8.69 | |
| Aptinyx | 0.4 | $4.4M | 1.9M | 2.34 | |
| Epizyme | 0.3 | $3.8M | 739k | 5.12 | |
| Allena Pharmaceuticals | 0.2 | $3.0M | 3.3M | 0.90 | |
| Essa Pharma Com New (EPIX) | 0.2 | $2.9M | 358k | 8.00 | |
| Kalvista Pharmaceuticals (KALV) | 0.2 | $2.7M | 157k | 17.45 | |
| Bellus Health Com New | 0.2 | $2.6M | 433k | 6.11 | |
| Galera Therapeutics (GRTX) | 0.2 | $2.0M | 241k | 8.10 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 0.2 | $1.9M | 550k | 3.41 | |
| Nabriva Therapeutics SHS | 0.0 | $507k | 426k | 1.19 |
